Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Citi downgrades BT to 'sell', expects Openreach revenue decline

(Sharecast News) - BT Group slumped on Tuesday as Citi downgraded its stance on the shares to 'sell' from 'buy' and cut the price target to 112p from 200p as it said that Openreach was facing a revenue decline. "We forecast Openreach turning to revenue decline in 2025/26 and staying there for the rest of the decade, which could see a negative shift in sentiment and questions as to whether BT will achieve its guidance for £3bn of normalised free cash flow by the end of the decade (Citi 2029/30E £2.3bn)," the bank said.

"We also have concerns around the sustainability of BT Consumer's pricing dynamic in the long-term, and based on our in-depth consensus tracker analysis, we also believe that consensus is overoptimistic in expecting restructuring specific item costs to reduce significantly in the next few years (Citi 2025/26E £401m versus consensus £250m)."

Citi also said it was adding BT to its focus list.

At 0910 GMT, the shares were down 5.6% at 143.05p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.